<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01237158</url>
  </required_header>
  <id_info>
    <org_study_id>nov 2010</org_study_id>
    <nct_id>NCT01237158</nct_id>
  </id_info>
  <brief_title>Genetic Association Study Between GAD1 and Reelin Polymorphisms and GABA/Glutamate MRS in Bipolar Disorder Type 1 and Healthy Controls: SPECGENE PROJECT</brief_title>
  <acronym>SPECGENE</acronym>
  <official_title>Genetic Association Study Between GAD1 and Reelin Polymorphisms and GABA/Glutamate MRS in Bipolar Disorder Type 1 and Healthy Controls: SPECGENE PROJECT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: The pathophysiological mechanisms of bipolar disorder are not completely
      clarified and several hypothesis have already been formulated including the role of
      monoamines, gama amino butyric acid (GABA) and glutamate. GABA is the main inhibitory
      neurotransmitter while glutamate is the main excitatory neurotransmitter. Genes that play a
      role in GABA metabolism and in the activity of GABA neurons are very important to understand
      the GABA function, once they affect neurodevelopment and its dysfunctions may predispose to
      neuropsychiatric diseases. The two genes that are going to be study in this project are
      glutamic acid decarboxylase (GAD1) and reelin (Reln). The enzyme glutamic acid descarboxylase
      (GAD67) metabolizes glutamate in GABA in the pre synaptic neuronal regions and is coded by
      the gene GAD1. Reelin is secretory serine protease with dual roles in mammalian brain:
      embryologically, it guides neurons and radial glial cells to their corrected positions in the
      developing brain; in adult brain, Reelin is involved in a signaling pathway which underlies
      neurotransmission, memory formation and synaptic plasticity. Magnetic resonance spectroscopy
      (MRS) studies on bipolar disorder show a number of alterations in cerebral level of GABA and
      glutamate in different cerebral areas when compared to healthy subjects and other mood
      disorders. Objective: Investigate in bipolar patients and healthy controls the association of
      GAD1 and Reln single nucleotide polymorphisms(SNP) and cerebral levels of GABA/glutamate on
      MRS. Methods: 70 symptomatic bipolar I patients medication free and 70 healthy controls are
      going to be genotyped for GAD1 and Reln SNPs and GABA/glutamate MRS.

      Key words: GAD1, GAD67, bipolar, GABA, Glutamate, Reelin, Rln, Spectroscopy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2010</start_date>
  <primary_completion_date type="Anticipated">October 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>association between GABA/glutamate brain levels and GAD1 polymorphisms</measure>
    <time_frame>single evaluation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>association between GABA/glutamate brain levels and Reelin polymorphisms</measure>
    <time_frame>single evaluation</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Bipolar Disorder</condition>
  <arm_group>
    <arm_group_label>healthy controls</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>bipolar disorder type I</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Bipolar Disorder Patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bipolar disorder type I diagnose (DSM-IV criteria)

          -  Medication free (4 last weeks)

        Exclusion Criteria:

          -  heavy smokers

          -  cannabis use

          -  recent alcohol abuse (14 days)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marcio G Soeiro-de-Souza, MD</last_name>
    <email>mgss@usp.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institute of Psychiatry HCFMUSP</name>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcio G Soeiro-de-Souza, MD</last_name>
      <email>mgss@usp.br</email>
    </contact>
    <investigator>
      <last_name>Marcio G Soeiro-de-Souza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.progruda.com</url>
  </link>
  <reference>
    <citation>Tost H, Lipska BK, Vakkalanka R, Lemaitre H, Callicott JH, Mattay VS, Kleinman JE, Marenco S, Weinberger DR. No effect of a common allelic variant in the reelin gene on intermediate phenotype measures of brain structure, brain function, and gene expression. Biol Psychiatry. 2010 Jul 1;68(1):105-7. doi: 10.1016/j.biopsych.2010.02.023.</citation>
    <PMID>20434133</PMID>
  </reference>
  <reference>
    <citation>Straub RE, Lipska BK, Egan MF, Goldberg TE, Callicott JH, Mayhew MB, Vakkalanka RK, Kolachana BS, Kleinman JE, Weinberger DR. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry. 2007 Sep;12(9):854-69. Epub 2007 May 1.</citation>
    <PMID>17767149</PMID>
  </reference>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 8, 2010</study_first_submitted>
  <study_first_submitted_qc>November 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2010</study_first_posted>
  <last_update_submitted>August 15, 2011</last_update_submitted>
  <last_update_submitted_qc>August 15, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 16, 2011</last_update_posted>
  <responsible_party>
    <name_title>Ricardo Alberto Moreno</name_title>
    <organization>University of Sao Paulo</organization>
  </responsible_party>
  <keyword>GAD1,</keyword>
  <keyword>GAD67,</keyword>
  <keyword>bipolar,</keyword>
  <keyword>GABA,</keyword>
  <keyword>Glutamate,</keyword>
  <keyword>Reelin,</keyword>
  <keyword>Rln,</keyword>
  <keyword>Spectroscopy</keyword>
  <keyword>euthymic bipolar I patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

